Champlain Investment Partners, LLC 13D and 13G filings for Cardiovascular Systems, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 3:24 pm Sale | 2023-12-31 | 13G | Cardiovascular Systems, Inc. CSII | Champlain Investment Partners, LLC | 0 0.000% | -2,338,085 (Position Closed) | Filing |
| 2023-02-13 1:26 pm Sale | 2022-12-31 | 13G | Cardiovascular Systems, Inc. CSII | Champlain Investment Partners, LLC | 2,338,085 5.580% | -1,150,540 (-32.98%) | Filing |
| 2022-02-11 10:55 am Purchase | 2021-12-31 | 13G | Cardiovascular Systems, Inc. CSII | Champlain Investment Partners, LLC | 3,488,625 8.600% | 417,455 (+13.59%) | Filing |
| 2021-02-12 1:24 pm Purchase | 2020-12-31 | 13G | Cardiovascular Systems, Inc. CSII | Champlain Investment Partners, LLC | 3,071,170 7.650% | 672,975 (+28.06%) | Filing |